Updated Treatment of Chronic Hepatitis B
10.3904/kjm.2019.94.3.252
- Author:
Eileen L YOON
1
;
Hyung Joon YIM
Author Information
1. Division of Gastroenterology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
- Publication Type:Review
- From:Korean Journal of Medicine
2019;94(3):252-262
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Chronic hepatitis B virus (HBV) infection is a major cause of liver cirrhosis and hepatocellular carcinoma in Korea. The prevalence of HBV infection is gradually decreasing in Korea, but 3.0% of the total population still suffers from HBV- related chronic liver diseases. In this review, we summarize the updated clinical practice guideline for management of chronic hepatitis B, as revised by the Korean Association for the Study of the Liver in 2018.
